
Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06)
Joaquim Bellmunt, José Manuel Trigo, Emiliano Calvo, Joan Carles, José L Pérez-Gracia, Jordi Rubió, Juan Antonio Virizuela, Rafael López, Martín Lázaro, Joan AlbanellVolume:
11
Année:
2010
Langue:
english
DOI:
10.1016/s1470-2045(09)70383-3
Fichier:
PDF, 291 KB
english, 2010